Company targets Phase 2 trial of oral Alzheimer’s drug that inhibits the activity of microglia to combat neuroinflammation. US biotech NeuroTherapia has secured $12.3 million in the first close of a Series B financing round to progress its mission to…
Browsing: All news
Category Added in a WPeMatico Campaign
New study shows that raising levels of fatty aci
On a mission to promote healthier eating habits,
Transferring regeneration-associated genes from
Company announces PIPE financing of up to $122 m
Part of $27 million fund to foster collaboration
New Alzheimer’s drug data highlights increased
Study identifies the nuclear protein Pin1 as piv
Seed round led by SV Health and Two Bear Capital
Study shows Shingrix vaccine may delay dementia